Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Kyorin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Kyorin's Japan sales performance.

Immuno-oncology in 2019: the rapid evolution continues

Immuno-oncology in 2019: the rapid evolution continues

BMS led the charge when Opdivo became the first in its class to gain approval (in metastatic melanoma in December 2014 in Japan), but Merck &Co’s Keytruda has emerged as

Pfizer closes on EU approval of lung cancer drug Vizimpro

Pfizer closes on EU approval of lung cancer drug Vizimpro The drug is also under regulatory review for this indication in the US and Japan, and the new use could help AZ compete in the market with SGLT2 rivals Invokana (canagliflozin)

Ashfield partners with MIMS, WA Health wins new account and Lighthouse relocates

Ashfield partners with MIMS, WA Health wins new account and Lighthouse relocates Ashfield operates across a further three regions – US, Japan and Europe, but hopes the new alliance will provide further expertise in data-driven market and events management.

IQVIA sees market slowdown looming for pharma

IQVIA sees market slowdown looming for pharma the next few years in the 3% to 6% range, mainly due to sluggish growth in Europe, and static or shrinking sales in Japan. ... On the other hand, in Japan for example it says that growth in new products will be strong and resistant to price cuts, despite

Unlocking the potential of science and technology in the UK

Unlocking the potential of science and technology in the UK The context here is worth keeping in mind. According to World Bank figures, Korea (4.2%), Japan (3.3%), the United States (2.8%), Germany (2.8%), Switzerland (2.4%), France

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics